Palynziq (Pegvaliase)

Pegvaliase, the active ingredient in Palynziq, is a pegylated enzyme presented as a solution for subcutaneous injection use. It treats phenylketonuria (PKU) in adults who require additional metabolic control. GNH USA supplies Palynziq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Palynziq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Palynziq is a therapeutic enzyme that targets the metabolic pathway of phenylalanine processing in phenylketonuria. - Phenylketonuria (PKU): Reduces blood phenylalanine concentrations, helping to maintain dietary management goals. - Adjunct to diet therapy: Allows patients to achieve better metabolic control when diet alone is insufficient. - Long‑term metabolic management: Supports sustained reduction of phenylalanine levels over time.

Common Side Effects: -   ...  -  ....  -  ....  -  ....  - ‑  ...  -  ... 

Serious or Rare Side Effects: -   ...  - ... 

Intro  t t